24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Amgen
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:25
SVP Shlomit Weiss leaving Intel amid engineering reorganization
22:06
Mobileye shares rise after securing order to ship at least 46 million new assisted driving chips
21:43
There’s a new humanoid in town: How does Amnon Shashua's MenteeBot stack up against the competition?
20:30
What are the economics behind Israel's air defense strategy?
More stories
Buzz
Most popular
Daily
Weekly
1
The price of failure: Dutch company's chip monopoly born from a bad bet by Intel
2
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
3
BeyondTrust acquiring permissions management startup Entitle for $100-150 million
4
Cyber on fire: Cybersecurity sector is breaking away from high-tech industry
5
Cyber unicorn Armis acquiring Silk Security for $150 million
More news
Amgen
2 stories about Amgen
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement
03.01.19
|
Lilach Baumer
In December, Teva reached a confidential settlement and licensing agreement with drug manufacturer Neos Therapeutics, regarding its generic version for Neos' ADHD drug
Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal
12.12.18
|
Lilach Baumer
The deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments
Please ensure Javascript is enabled for purposes of
website accessibility